LncRNA FGF13-AS1 disrupts the interaction between IGF2BP1 and Myc mRNA through the FGF13-AS1/IGF2BP1/Myc axis, inhibiting glycolysis and stemness of breast cancer cells. Here, MYC is linked to breast carcinoma.